Renaissance BioScience, VIDO target two global pig diseases
One project to examine orally delivered yeast-based vaccines for PEDV and PRRSV.
Stay updated with breaking news from John Husnik. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
One project to examine orally delivered yeast-based vaccines for PEDV and PRRSV.
Renaissance BioScience, a leader in bioengineering microbes for the global agriculture and food industries, has signed a joint development agreement (JDA) with Certis Belchim, a global leader in the development of crop-protecting biocontrol agents that combat agricultural pests.
Vancouver, Canada, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Renaissance BioScience Corp (www.renaissancebioscience.com), a leader in bioengineering for the global agriculture, animal health, human medicine, and food sector, is pleased to announce its recent patent award from the China patent office. This patent grant, representing the first for its innovative yeast-based platform technology for the production and delivery of RNA bioactive molecules, enhances Renaissance's robust IP portfolio, which inc
Renaissance’s non-GMO acrylamide-reducing yeast is a proven commercially available clean-label ingredient that reduces the formation of the carcinogen acrylamide in many common cooked foods, including biscuits, chips, crackers, bread, cereals […]
Vancouver, Canada — Renaissance BioScience Corp., a leading global bioengineering company, is pleased to officially announce the publication of a landmark paper on lager yeast development in the February 2021 issue of Applied and Environmental Microbiology (Volume 87, Issue 3). “Industrially Applicable De Novo Lager Yeast Hybrids with a Unique Genome Architecture: Creation and Characterization,” by Turgeon et al, explains how the Renaissance research team developed an innovative approach in creating novel non-GMO lager yeast strains that are immediately suitable for lager beer productio...